Table 6.
IV Estimates of | |||
---|---|---|---|
Impact of CATH: | Impact of $1000: | ||
Sample: | on 1-Year Survival | on 1-year Cost ($1000s) | on 1-year Survival |
1. All patients | |||
HRR risk-adjusted CATH rate: | |||
a. Above the Median (n=63,771) | 0.256 (0.061) | 6.691 (3.510) | 0.038 (0.021) |
b. Below the Median (n=66,124) | 0.09 (0.059) | 9.835 (3.155) | 0.009 (0.007) |
Difference: | 0.166 (0.085) | −3.144 (4.720) | 0.029 (0.022) |
2. Patients above the median CATH propensity | |||
HRR risk-adjusted CATH rate: | |||
a. Above the Median (n=32,388) | 0.271 (0.064) | 0.347 (4.370) | 0.78 (9.820) |
b. Below the Median (n=32,411) | 0.168 (0.046) | 4.962 (2.890) | 0.034 (0.021) |
3. Patients below the median CATH propensity | |||
HRR risk-adjusted CATH rate: | |||
a. Above the Median (n=31,383) | 0.206 (0.129) | 16.21 (5.130) | 0.013 (0.009) |
b. Below the Median (n=33,713) | −0.139 (0.165) | 22.064 (6.870) | −0.006 (0.007) |
Notes: HRR intensity rates are computed as the risk-adjusted fixed effects from a patient level regression the receipt of CATH or beta-blockers on HRR fixed effects and CCP risk-adjusters. Differential-distance (measured as the distance between the patient’s zip-code of residence and the nearest catheterization hospital minus the distance to the nearest hospital) is the instrument. Each model includes all the CCP risk-adjusters and the standard errors are clustered at the level of each HRR.